By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biomarker discovery company WaferGen plans to open a European headquarters in Luxembourg, the company said today.

The new facility in central Europe would include sales and marketing, service and support, distribution, some research and development, and management of distributors and subsidiaries, the Freemont, Calif.-based company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.